India has administered more than 1.7 billion doses, including 20 million in the 15 to 18 age group. At present, India uses domestically produced Bharat Biotech’s Covaxin for adolescents aged between 15 and 18.
India has administered more than 1.7 billion doses, including 20 million in the 15 to 18 age group. At present, India uses domestically produced Bharat Biotech’s Covaxin for adolescents aged between 15 and 18.
